GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » EV-to-Revenue

Shanghai HeartCare Medical Technology (HKSE:06609) EV-to-Revenue : -0.12 (As of May. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shanghai HeartCare Medical Technology's enterprise value is HK$-30.0 Mil. Shanghai HeartCare Medical Technology's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$254.1 Mil. Therefore, Shanghai HeartCare Medical Technology's EV-to-Revenue for today is -0.12.

The historical rank and industry rank for Shanghai HeartCare Medical Technology's EV-to-Revenue or its related term are showing as below:

HKSE:06609' s EV-to-Revenue Range Over the Past 10 Years
Min: -4.57   Med: 0.56   Max: 278.38
Current: -0.1

During the past 5 years, the highest EV-to-Revenue of Shanghai HeartCare Medical Technology was 278.38. The lowest was -4.57. And the median was 0.56.

HKSE:06609's EV-to-Revenue is ranked better than
97.11% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.24 vs HKSE:06609: -0.10

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-20), Shanghai HeartCare Medical Technology's stock price is HK$18.48. Shanghai HeartCare Medical Technology's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$6.68. Therefore, Shanghai HeartCare Medical Technology's PS Ratio for today is 2.77.


Shanghai HeartCare Medical Technology EV-to-Revenue Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology EV-to-Revenue Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - 23.74 2.51 1.60

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only 23.74 - 2.51 - 1.60

Competitive Comparison of Shanghai HeartCare Medical Technology's EV-to-Revenue

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's EV-to-Revenue falls into.



Shanghai HeartCare Medical Technology EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shanghai HeartCare Medical Technology's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-30.022/254.133
=-0.12

Shanghai HeartCare Medical Technology's current Enterprise Value is HK$-30.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai HeartCare Medical Technology's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$254.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai HeartCare Medical Technology  (HKSE:06609) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shanghai HeartCare Medical Technology's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=18.48/6.675
=2.77

Shanghai HeartCare Medical Technology's share price for today is HK$18.48.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$6.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai HeartCare Medical Technology EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines